Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Migraine Prophylaxis
NCT00739024Phase 2Terminated
- Sponsor
- Swedish Health Services
- Start
- Apr 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ramelteon in migraine (2 arms), sponsored by Swedish Health Services. Primary endpoint: Reduction in number of migraine headaches at 12 weeks. Started Apr 2008; status: terminated.
02
Drugs
ramelteon
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00739024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739024.